Health & Medicinearticle2026-11-08

Genomic, single-cell, and functional profiling of the CD48-CD244 axis and NK cell dysfunction in multiple myeloma

Open access0 citations

Abstract

Abstract Multiple myeloma (MM) orchestrates immune evasion by subverting natural killer (NK) cell function. CD48, one of the most abundant NK-ligands on MM cells, paradoxically enhances NK-cell activation yet is associated with high-risk cytogenetics and poor patient survival. We integrated multi-omics (bulk and single-cell RNA-seq, ATAC-seq), genome-wide CRISPR-KO/a screens, and machine learning to dissect CD48 regulation and function. In human MM and Vκ*MYC mice scRNA-seq datasets, NK cells exhibit stepwise increases in inflammatory and exhaustion signatures and loss of cytotoxic potential as disease progresses. In vitro co-culture assays show CD48 overexpression on MM enhances initial NK-cell cytotoxicity and cytokine secretion, whereas chronic exposure leads to ex vivo NK dysfunction. In vivo, CD48-overexpressing Vκ*MYC tumors progress more slowly and extend host survival, while NK-cell depletion accelerates disease. These findings support a context-dependent role for CD48, potentiating acute NK responses while coexisting with chronic NK exhaustion, and suggest strategies to modulate CD48 for therapeutic benefit.

// Source

View paper (DOI)Open access versionOpenAlexJCI InsightPublished 2026-11-08

Authors: Bonell Patiño-Escobar, Torsten Steinbrunn, Lucy Maritza Pérez Lugo, Sham Rampersaud, Daniel Dirck Waller, Daniela Ordoñez, Huimin Geng, Fernando Salangsang, Paul Phojanakong, Juan Antonio Camara Serrano, Yan Zeng, Veronica Steri, Oscar A. Aguilar, Constantine S. Mitsiades, Arun P. Wiita

Institutions: Harvard University, University of California, San Francisco, Universitätsklinikum Würzburg, Massachusetts Institute of Technology, Broad Institute, Dana-Farber Cancer Institute, Chan Zuckerberg Biohub San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, Parker Institute for Cancer Immunotherapy, City College of San Francisco, Fundación Valle del Lili